Presentation Resources:
-The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
-Smid, Schauberger. “Methamphetamine in Pregnancy – 2022” ASAM conference May 2022, Hollywood Florida, Lecture
- Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med 2015;9(2):11
-Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009;113(6):1285–129. Abstract
- Towers CV, Pircon RA, Nageotte MP, Porto M, Garite TJ. Cocaine intoxication presenting as preeclampsia and eclampsia. Obstet Gynecol 1993;81(4):545–54. Abstract
- Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007;19(6):578–585. Abstract
- Woods JR, Plessinger MA. Pregnancy increases cardiovascular toxicity to cocaine. Am J Obstet Gynecol 1990;162(2):529–533. Abstract
- Plessinger MA, Woods JR. Progesterone increases cardiovascular toxicity to cocaine in nonpregnant ewes. Am J Obstet Gynecol 1990;163(5):1659–1664
- Plessinger MA, Woods JR Jr. The cardiovascular effects of cocaine use in pregnancy. Reprod Toxicol 1991;5(2):99–113. First page preview
- Plessinger MA, Woods JJ. Maternal, placental, and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol 1993;36(2):267–278. Abstract
- Gouin K, Murphy K, Shah PS. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011;204(4):340 e341–340. e312. Abstract
- Fares I, McCulloch KM, Raju T. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis In:1997
- Shah R, Diaz SD, Arria A, et al. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol 2012;29(5):391
- Derauf C, LaGasse LL, Smith LM, et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). The American journal of drug and alcohol abuse 2007;33(2):281–289
- Admon LK, Bart G, Kozhimannil KB, Richardson CR, Dalton VK, Winkelman NA. Amphetamine- and opioid affected births: Incidence, outcomes, and costs, United States, 2004-2015. Am J Public Health 2019;109;148-54.
- Good MM, Solt I, Acuna JG, Rotmensch S, Kim MJ. Methamphetamine use during pregnancy: maternal and neonatal implications. Obstet Gynecol 2010;116:330-4
- Gabrhelik R, Skurtveit S, Nechanska B, Handal M, Mahic M, Mravcik. Prenatal methamphetamine exposure and adverse neonatal outcomes: A nationwide cohort study. Eur Addict Res 2021;27:97-106.
- Trivedi, Madhukar H., et al. Bupropion and naltrexone in methamphetamine use disorder. New England Journal of Medicine 2021;384:140-53
- Smid M, Metz T, Gordon A. Stimulant Use in Pregnancy – an under-recognized epidemic among pregnant women. Clin Obstet Gynecol. 2019; 62(1) 168-184
- Wright, Ginsberg, Parkinson, Dubose, Sherbondy, Shores. Outcomes of Mothers and Newborns to prenatal exposure to Kratom: a systemic review. Journal of Perinatology 2021; 41(6):1236-1243